Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

肝細胞性がん (HCC) は肝細胞性がん (HCC) と呼ばれる.

R S Dawe

    Lancet (London, England)
    |March 20, 2004
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen disease.

    The British journal of dermatology·2021
    Same author

    Photodiagnostic services in the UK and Republic of Ireland: a British Photodermatology Group Workshop Report.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2021
    Same author

    Response to 'Decline in the use of phototherapy in France from 2010 to 2019'.

    The British journal of dermatology·2021
    Same author

    Methotrexate combined with omalizumab for difficult to treat urticaria: a further step-up treatment?

    Clinical and experimental dermatology·2020
    Same author

    No association between whole-body ultraviolet A1 phototherapy and skin cancers in humans: a cancer registry linkage study.

    The British journal of dermatology·2020
    Same author

    Choice of topical prodrug in daylight photodynamic therapy for actinic keratoses.

    The British journal of dermatology·2019
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る